Matches in Wikidata for { <http://www.wikidata.org/entity/Q64395663> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q64395663 description "assaig clínic" @default.
- Q64395663 description "clinical trial" @default.
- Q64395663 description "clinical trial" @default.
- Q64395663 description "clinical trial" @default.
- Q64395663 description "clinical trial" @default.
- Q64395663 description "ensaio clínico" @default.
- Q64395663 description "ensayo clínico" @default.
- Q64395663 description "ensayu clínicu" @default.
- Q64395663 description "essai clinique" @default.
- Q64395663 description "klinisch onderzoek" @default.
- Q64395663 description "клінічне випробування" @default.
- Q64395663 name "FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)" @default.
- Q64395663 type Item @default.
- Q64395663 label "FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)" @default.
- Q64395663 prefLabel "FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)" @default.
- Q64395663 P1050 Q64395663-C1C97180-DF48-439A-9876-BF7722C30C12 @default.
- Q64395663 P1050 Q64395663-FF9B7870-8019-4F09-A8B2-A52C213B3F0F @default.
- Q64395663 P1132 Q64395663-A82FBF48-0293-435D-919C-3082FA86E918 @default.
- Q64395663 P1476 Q64395663-42B8CAA2-69B2-4363-9AD2-AE9DE1034DDE @default.
- Q64395663 P17 Q64395663-59B4C2DB-2D05-4DB2-8533-6491E0CE1097 @default.
- Q64395663 P2899 Q64395663-1059C923-3FE3-4CC2-8DAF-4EB7197B7D93 @default.
- Q64395663 P3098 Q64395663-1A6D3EA7-6887-4128-9784-BAD449D67DFA @default.
- Q64395663 P31 Q64395663-A59B964D-5354-4F7A-A9FC-B5E66D6C3EC2 @default.
- Q64395663 P4844 Q64395663-729F9D62-2B3A-4A11-BD3E-A3A478604F73 @default.
- Q64395663 P580 Q64395663-D3DBB83A-E5C5-4EB4-B9F3-79DE1E8398CC @default.
- Q64395663 P582 Q64395663-F43798F7-CD04-4D0E-8F58-AE1505CB195B @default.
- Q64395663 P6099 Q64395663-D438B57A-6D07-4763-A682-09B01EAF99EA @default.
- Q64395663 P6153 Q64395663-036F70AB-2D0C-4236-AAFA-AD6D335956E0 @default.
- Q64395663 P6153 Q64395663-09FCCF91-D4B3-4383-B59F-D08B122435B2 @default.
- Q64395663 P6153 Q64395663-15F436AD-9259-4A7B-B1BF-3500049AA463 @default.
- Q64395663 P6153 Q64395663-3C76CDAB-0F82-4D6C-A85E-37BCDC606BD5 @default.
- Q64395663 P6153 Q64395663-4A713AAB-5F29-4637-ACB2-76523265F7A1 @default.
- Q64395663 P6153 Q64395663-50741863-C52C-4193-AF24-6A24B401293D @default.
- Q64395663 P6153 Q64395663-7570132F-C026-40F4-9597-1411D9CD4B05 @default.
- Q64395663 P6153 Q64395663-7725D6AC-CCB4-4BC2-8C6A-2F599F2F437F @default.
- Q64395663 P6153 Q64395663-90E05F2B-1015-4C23-8307-6E678A836F35 @default.
- Q64395663 P6153 Q64395663-96476E9D-0B05-48BC-8031-E5042EC422A2 @default.
- Q64395663 P6153 Q64395663-9D778F30-F159-4B15-8FB5-D8FB9E9CFDBF @default.
- Q64395663 P6153 Q64395663-A8EB76E2-B4CB-426C-BCC3-9AE122C9B087 @default.
- Q64395663 P6153 Q64395663-ADDFA429-B00C-474D-B87B-B2DF1F172793 @default.
- Q64395663 P6153 Q64395663-B6CC0DBC-F435-45FA-B6D3-0FC833F2253D @default.
- Q64395663 P6153 Q64395663-CA47BDB5-2F38-4874-B4C1-BD1EE47C9F47 @default.
- Q64395663 P6153 Q64395663-D28B2921-FFD6-44B4-8BB9-9E1EADD7E0C7 @default.
- Q64395663 P6153 Q64395663-D2CED09E-92F3-423D-AEED-4DE3D5CB25A5 @default.
- Q64395663 P6153 Q64395663-EF6F1270-89B4-48BC-9369-62356849DAC0 @default.
- Q64395663 P6153 Q64395663-F09DFF14-AC5A-48CE-B57D-FE7515A17C3E @default.
- Q64395663 P8363 Q64395663-E5C797E0-2EAC-41C2-B950-FD1EFEBCCF3B @default.
- Q64395663 P1050 Q1891209 @default.
- Q64395663 P1050 Q208414 @default.
- Q64395663 P1132 "+160" @default.
- Q64395663 P1476 "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma" @default.
- Q64395663 P17 Q30 @default.
- Q64395663 P2899 "+18" @default.
- Q64395663 P3098 "NCT02448381" @default.
- Q64395663 P31 Q30612 @default.
- Q64395663 P4844 Q425409 @default.
- Q64395663 P580 "2015-12-01T00:00:00Z" @default.
- Q64395663 P582 "2019-12-01T00:00:00Z" @default.
- Q64395663 P6099 Q42824827 @default.
- Q64395663 P6153 Q1047060 @default.
- Q64395663 P6153 Q1070333 @default.
- Q64395663 P6153 Q1130172 @default.
- Q64395663 P6153 Q1193547 @default.
- Q64395663 P6153 Q16996992 @default.
- Q64395663 P6153 Q238101 @default.
- Q64395663 P6153 Q2415975 @default.
- Q64395663 P6153 Q29052 @default.
- Q64395663 P6153 Q309350 @default.
- Q64395663 P6153 Q41506 @default.
- Q64395663 P6153 Q500606 @default.
- Q64395663 P6153 Q503415 @default.
- Q64395663 P6153 Q503419 @default.
- Q64395663 P6153 Q5225736 @default.
- Q64395663 P6153 Q6806451 @default.
- Q64395663 P6153 Q750639 @default.
- Q64395663 P6153 Q777403 @default.
- Q64395663 P6153 Q7896459 @default.
- Q64395663 P6153 Q969850 @default.
- Q64395663 P8363 Q78089383 @default.